nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['nivolumab', 'check,mate,214', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'award', 'renal,(-adrenal)', 'kidney cancer', 'ipiniv', 'check,mate,275', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'biomarker', 'nivo', ' uc,(-ucsd),(-ucsf),', 'marker ']
please stop by our biomarker-driven optic rcc trial-in-progress poster (tps 742) lead by , anupama reddy ,yu shyr , natalia mar #gu23 
Med Onc Fellow @VUMC_CANCER |Aspiring GU Oncologist | Former IM Resident @ClevelandClinic | Views my own | RT≠endorsement